Amryt Pharma PLC's (LON:AMYT) Joe Wiley catches up with Proactive to discuss the company's 'major' new licensing deal with University College Dublin for a gene therapy asset.
He says the company is seeing encouraging early data and is planning to conduct pre-clinical studies in the coming months.
Meet AusCann Group Holdings Ltd, Pacific American Coal Ltd, Kasbah Resources, Hazer Group Ltd and Kazia Therapeutics Ltd at our event,Sydney, 19 March 2018.Register here >>